TheStreetJohnson & Johnson Suspends Vaccine Sales Guidance, Boosts Dividend; Stock Hits Record HighApr 19, 2022more_vert
FiercePharmaJohnson & Johnson drops COVID-19 vaccine projections, reduces 2022 revenue forecastApr 19, 2022Kevin DunleavyBy Kevin Dunleavymore_vert